Dexcom takes G6 CGM to Singapore
World CGM gadget maker Dexcom has launched its newest CGM system in Singapore.
Distributed by way of its associate DKSH Singapore, the prick-less Dexcom G6 CGM makes use of a wearable sensor and transmitter to constantly measure and ship glucose ranges wirelessly to a suitable good gadget.
It pairs with a companion cellular app on iOS and Android gadgets, enabling the sharing of glucose information with as much as ten folks, together with households and healthcare groups.
The launch of the Dexcom G6 comes after it obtained approval from the Well being Sciences Authority late final yr and the latest opening of the Dexcom regional headquarter within the nation.
Molbio takes majority stake in digital x-ray maker Prognosys
Indian medical gadget unicorn firm Molbio Diagnostics has acquired a 70% stake in Prognosys Medical Techniques.
Prognosys develops radiology and fluoroscopy options below the Prorad model. It has not too long ago launched a line of digital x-ray models that provides high-quality chest imaging powered by AI.
Its mixture with Molbio’s Truenat testing package will improve the prognosis of lethal communicable and non-communicable illnesses comparable to tuberculosis, COVID-19, and different chest-related situations in massive populations, in response to Molbio. Truenat is a WHO-endorsed point-of-care PCR platform that may display screen over 40 illnesses inside an hour.
2C2P gives fee capabilities to DKSH’s affected person platform
The healthcare enterprise unit of DKSH Singapore has tapped 2C2P to construct new fee capabilities for its affected person engagement administration platform.
Via this partnership, sufferers on DKSH’s PSPhere platform can now apply for rebates, instalment plans, and e-wallets in a “safe and compliant” method, in response to a press assertion.